ATPW
NVO

Ashton Thomas Private Wealth’s Novo Nordisk NVO Stock Holding History

Ashton Thomas Private Wealth’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.8M Buy
76,210
+65,056
+583% +$3.08M 0.07% 292
2025
Q4 		$568K Sell
11,154
-4,676
-30% -$239K 0.01% 627
2025
Q3 		$878K Sell
15,830
-8,714
-36% -$510K 0.02% 502
2025
Q2 		$1.69M Buy
24,544
+2,604
+12% +$177K 0.06% 311
2025
Q1 		$1.55M Sell
21,940
-424
-2% -$35K 0.06% 299
2024
Q4 		$1.92M Buy
22,364
+6,454
+41% +$698K 0.07% 278
2024
Q3 		$1.89M Buy
15,910
+1,165
+8% +$155K 0.1% 223
2024
Q2 		$2.1M Buy
14,745
+209
+1% +$27.7K 0.12% 192
2024
Q1 		$1.87M Buy
14,536
+2,374
+20% +$283K 0.11% 212
2023
Q4 		$1.26M Buy
12,162
+6,210
+104% +$614K 0.08% 257
2023
Q3 		$541K Buy
5,952
+1,482
+33% +$131K 0.04% 384
2023
Q2 		$362K Buy
+4,470
New +$365K 0.03% 455

Other funds holding NVO

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
DAM
Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return

Ashton Thomas Private Wealth's NVO Position: Q1 2026 in Review

Ashton Thomas Private Wealth increased its Novo Nordisk (NVO) stake by 583% in Q1 2026, buying an estimated $3.08M and bringing the position to 76,210 shares worth $2.8M. The position accounts for 0.07% of the portfolio, ranked #292.

Ashton Thomas Private Wealth first reported a position in NVO in Q2 2023 and has held it in 12 quarters since. 1,272 funds tracked by Wall St. Rank hold NVO as of Q1 2026.

  • Ashton Thomas Private Wealth held 76,210 shares of Novo Nordisk worth $2.8M as of Q1 2026.
  • Ashton Thomas Private Wealth bought 65,056 Novo Nordisk shares in Q1 2026, an estimated $3.08M.
  • Novo Nordisk made up 0.07% of Ashton Thomas Private Wealth's portfolio in Q1 2026, its #292 holding.
  • Ashton Thomas Private Wealth first reported a position in Novo Nordisk in Q2 2023 and has held it in 12 quarters since.
  • 1,272 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2026.

Based on Ashton Thomas Private Wealth's 13F filing for Q1 2026, filed 11 May 2026.